Kidney dopamine D1-like receptors and angiotensin 1-7 interaction inhibits renal Na+ transporters

Am J Physiol Renal Physiol. 2019 Oct 1;317(4):F949-F956. doi: 10.1152/ajprenal.00135.2019. Epub 2019 Aug 14.

Abstract

The role of dopamine D1-like receptors (DR) in the regulation of renal Na+ transporters, natriuresis, and blood pressure is well established. However, the involvement of the angiotensin 1-7 (ANG 1-7)-Mas receptor in the regulation of Na+ balance and blood pressure is not clear. The present study aimed to investigate the hypothesis that ANG 1-7 can regulate Na+ homeostasis by modulating the renal dopamine system. Sprague-Dawley rats were infused with saline alone (vehicle) or saline with ANG 1-7, ANG 1-7 antagonist A-779, DR agonist SKF38393, and antagonist SCH23390. Infusion of ANG 1-7 caused significant natriuresis and diuresis compared with saline alone. Both natriuresis and diuresis were blocked by A-779 and SCH23390. SKF38393 caused a significant, SCH23390-sensitive natriuresis and diuresis, and A-779 had no effect on the SKF38393 response. Concomitant infusion of ANG 1-7 and SKF38393 did not show a cumulative effect compared with either agonist alone. Treatment of renal proximal tubules with ANG 1-7 or SKF38393 caused a significant decrease in Na+-K+-ATPase and Na+/H+ exchanger isoform 3 activity. While SCH23390 blocked both ANG 1-7- and SKF38393-induced inhibition, the DR response was not sensitive to A-779. Additionally, ANG 1-7 activated PKG, enhanced tyrosine hydroxylase activity via Ser40 phosphorylation, and increased renal dopamine production. These data suggest that ANG 1-7, via PKG, enhances tyrosine hydroxylase activity, which increases renal dopamine production and activation of DR and subsequent natriuresis. This study provides evidence for a unidirectional functional interaction between two G protein-coupled receptors to regulate renal Na+ transporters and induce natriuresis.

Keywords: Na+-K+-ATPase; Na+/H+ exchanger; natriuresis; renal tubules.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine / pharmacology
  • Angiotensin I / antagonists & inhibitors
  • Angiotensin I / pharmacology*
  • Animals
  • Benzazepines / pharmacology
  • Cyclic GMP-Dependent Protein Kinases / metabolism
  • Diuresis / drug effects
  • Dopamine / biosynthesis
  • Dopamine Agonists / pharmacology
  • Dopamine Antagonists / pharmacology
  • Kidney / metabolism*
  • Natriuresis / drug effects
  • Peptide Fragments / antagonists & inhibitors
  • Peptide Fragments / pharmacology*
  • Rats
  • Rats, Sprague-Dawley
  • Receptors, Dopamine D1 / metabolism*
  • Receptors, G-Protein-Coupled / drug effects
  • Receptors, G-Protein-Coupled / metabolism*
  • Sodium / metabolism*
  • Sodium-Hydrogen Exchangers / metabolism
  • Sodium-Potassium-Exchanging ATPase / metabolism

Substances

  • Benzazepines
  • Dopamine Agonists
  • Dopamine Antagonists
  • Peptide Fragments
  • Receptors, Dopamine D1
  • Receptors, G-Protein-Coupled
  • SCH 23390
  • Sodium-Hydrogen Exchangers
  • 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine
  • Angiotensin I
  • Sodium
  • Cyclic GMP-Dependent Protein Kinases
  • Sodium-Potassium-Exchanging ATPase
  • angiotensin I (1-7)
  • Dopamine